Corbus Pharmaceuticals Holdings, Inc.
USD8.97
-0.01 (-0.11%)
CEO
Yuval Cohen
IPO Date
2014-10-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.06
Prev. Close
$8.98
Day Low
$8.89
Day High
$9.17
52W Low
$6.72
52W High
$20.56
Market Cap
$0.11B
Volume
0.07M
| -3.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 646.0% | -157.8% | -3.02 | 0.74 | -0.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -169.2% | -84.2% | 0.76 | 4.76 | -0.2 |
| 31 Dec 2021 | FY | -85.9% | -5166.4% | -65.9% | -42.3% | 0.38 | 5.89 | -1.7 |
| 31 Dec 2020 | FY | 100.0% | -2826.1% | -245.8% | -108.8% | 0.59 | 2.89 | -0.9 |
| 31 Dec 2019 | FY | -147.9% | -197.7% | -1160.4% | -145.4% | 1.53 | 1.09 | -4.9 |
| 31 Dec 2018 | FY | -908.1% | -1154.5% | -202.3% | -118.5% | 0.01 | 2.45 | -6.0 |
| 31 Dec 2017 | FY | -967.1% | -1328.6% | -56.1% | -48.4% | 0.01 | 7.98 | -11.0 |
| 31 Dec 2016 | FY | -707.6% | -1046.3% | -224.2% | -111.8% | 0.03 | 1.96 | -17.4 |
| -1.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -25.3% | -21.3% | 0.02 | 6.31 | -1.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -15.9% | -14.1% | 0.02 | 9.21 | -1.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -13.4% | -12.1% | 0.02 | 11.82 | -1.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -6.7% | -6.1% | 0.02 | 12.94 | -3.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -9.2% | -8.4% | 0.02 | 13.84 | -4.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -8.0% | -6.6% | 0.12 | 6.18 | -3.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -7.1% | -5.5% | 0.18 | 4.69 | -3.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 116.2% | -28.4% | -3.02 | 0.74 | -0.8 |